News

How creativity and wisdom can grow after 80, from Matisse to modern psychiatry—boosting purpose, brain health, and connection in later life.

"While studying the CAT scan, I picture Groucho Marx..."

Bupropion may cause dose-linked tinnitus; this case shows symptoms improve after dose reduction, helping manage depression without stopping treatment.

Shared pathophysiology between Alzheimer disease and autism may expand diagnosis and treatment opportunities.

A new US-based grant program seeks to create training content for health care providers who want to be able to deliver investigational COMP360 psilocybin treatment.

Explore how sigma‑1 receptors shape ER–mitochondria signaling, calm neuroinflammation, and inspire therapies from fluvoxamine to dextromethorphan.

Psychiatry training must catch up with chatbot literacy, intake, safety, ethics, and supervised AI integration.

With Artemis II’s journey in mind, a psychiatrist urges mental health action on climate denial, resilience, and saving Earth before it’s too late.

A pharma expert and clinician shares perspectives on developing treatments.

“Each person the right to tell their own story in their own way”: An Italian-Canadian psychiatrist traces family journeys across 3 countries, revealing migration’s lessons on identity, belonging, and resilience.

Exercise boosts recovery in depression and psychosis, and improves cognition and quality of life; clinicians can now use the 5A model to make movement a routine psychiatric tool.

Artemis II astronauts spark a psychiatrist’s look at “joy trains,” music, and meaning—practical ways teams rekindle joy and prevent burnout.

Reality TV puts therapy on camera, reducing stigma but raising ethical, privacy, and misinformation risks—and affecting viewers and cast.

New ASAM youth criteria redefine SUD care with brain-stage levels, chronic monitoring, detox safety, and family-centered support.

From Artemis II’s fiery return to life after prison or vacation, this article shows how reentry stress becomes a skill for growth.

To prescribe or not to prescribe?

Deep intracranial frequency stimulation 77.5 Hz high-gamma approach was associated with statistically significant reductions in self-injury behaviors and depressive symptoms in female adolescents with nonsuicidal self-injury.

What can the Artemis II astronauts tell us about both outer space and the inner space of our minds?

BPL-003 phase 2a part 2 results show reductions in depression symptoms.

A new US Department of War backed phase 2a study will test BXCL501's efficacy in easing acute stress reactions and preventing PTSD.

Stroke recovery lasts years; learn why fatigue, sleep, hormones and cognition demand ongoing rehab beyond 90 days—and how progress can continue.

Experts share how roluperidone provides a new opportunity in the schizophrenia treatment landscape.

Early MRS data show AL001 delivers lithium effects across the brain while sparing glutamate, hinting at better tolerability than lithium carbonate.

How is artificial intelligence affecting human intelligence?

Remembering 2 child and adolescent psychiatrists...

Should hospitals be required to integrate AI-driven risk stratification into emergency department workflows to maintain accreditation? Join the debate.

As Canada approaches the planned implementation of their medical euthanasia program for patients with sole psychiatric illnesses, these authors make an argument as to why euthanasia should remain closed to patients with psychiatric disorders.

Remembering Donald P. Hay, MD, and other deceased psychiatric colleagues.